Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net interest income | -0.03%2.67B | 4.82%10.86B | 5.83%7.82B | 1.04%5.35B | -6.38%2.67B | -11.71%10.36B | -18.10%7.39B | -10.64%5.3B | -3.04%2.86B | -4.20%11.74B |
| -Interest income | -0.85%5.8B | 1.49%23.7B | 2.05%17.47B | -0.37%11.73B | -3.86%5.85B | -5.67%23.36B | -9.11%17.12B | -5.00%11.78B | -1.15%6.08B | -1.19%24.76B |
| -Interest expense | 1.53%-3.12B | 1.16%-12.84B | 0.83%-9.65B | 1.53%-6.38B | 1.63%-3.17B | 0.22%-12.99B | 0.84%-9.73B | -0.16%-6.48B | -0.59%-3.23B | -1.69%-13.02B |
| Net service income | 18.33%120.49M | -13.95%406.39M | -7.09%325.05M | -11.94%234.25M | -7.78%101.82M | -18.42%472.26M | -20.89%349.85M | -17.42%266M | -31.62%110.41M | -26.80%578.93M |
| -Service income | 12.64%149.82M | -13.00%541.55M | -6.16%426.81M | -12.14%298.46M | -7.38%133.01M | -15.41%622.46M | -17.69%454.81M | -14.24%339.71M | -25.56%143.61M | -21.52%735.88M |
| -Service charge | 5.94%-29.33M | 10.01%-135.16M | 3.05%-101.76M | 12.89%-64.21M | 6.06%-31.19M | 4.30%-150.2M | 4.88%-104.96M | 0.41%-73.71M | -5.53%-33.2M | -6.91%-156.95M |
| Net transaction income | 43.67%125.03M | -65.08%368.25M | -36.48%391.63M | -56.18%197.3M | -42.84%87.02M | 34.89%1.05B | 5.88%616.52M | 12.22%450.28M | 240.28%152.24M | -46.40%781.75M |
| Securities and investments income | -6.08%570.62M | 23.86%1.13B | 32.24%840.65M | 168.34%895.22M | 148.48%607.55M | 84.81%912.72M | 87.63%635.72M | 72.28%333.61M | 87.66%244.51M | -14.12%493.88M |
| Special items of operating revenue | 116.66%19.35M | 99.33%171.95M | -55.05%33.06M | -67.15%19.61M | -79.88%8.93M | -18.04%86.26M | -12.19%73.55M | -1.84%59.71M | 254.76%44.37M | -28.66%105.25M |
| Operating revenue | 0.84%3.51B | 0.39%12.94B | 3.81%9.41B | 4.56%6.7B | 2.10%3.48B | -5.91%12.89B | -13.41%9.06B | -7.22%6.41B | 3.43%3.41B | -10.03%13.7B |
| Operating expenses - before deducting impairment | 17.31%-550.25M | 3.80%-3.76B | 1.95%-2.39B | 6.27%-1.56B | -0.90%-665.48M | -1.18%-3.9B | -3.86%-2.44B | -9.26%-1.66B | 1.48%-659.53M | -5.52%-3.86B |
| Operating profit before deducting impairment | 5.13%2.96B | 2.22%9.19B | 5.93%7.02B | 8.36%5.14B | 2.39%2.81B | -8.69%8.99B | -18.40%6.62B | -11.88%4.74B | 4.68%2.75B | -14.94%9.84B |
| Impairment and provisions | -3.92%-1.66B | -1.37%-7.28B | -7.73%-4.36B | -10.86%-3.17B | -0.72%-1.6B | 11.04%-7.18B | 15.65%-4.05B | 0.58%-2.86B | -40.53%-1.59B | 6.75%-8.08B |
| -Impairment losses of other assets | -3.92%-1.66B | -1.37%-7.28B | -7.73%-4.36B | -10.86%-3.17B | -0.72%-1.6B | 11.04%-7.18B | 15.65%-4.05B | 0.58%-2.86B | -40.53%-1.59B | 6.75%-8.08B |
| Operating profit after deducting impairment | 6.73%1.29B | 5.60%1.9B | 3.10%2.66B | 4.55%1.97B | 4.67%1.21B | 2.10%1.8B | -22.39%2.58B | -24.88%1.88B | -22.46%1.16B | -39.31%1.77B |
| Operating expenses - after deducting impairment | -6.84%-4.14M | -6.01%-16M | -1.85%-11.19M | -3.80%-7.51M | -11.22%-3.88M | -76.78%-15.09M | ---10.98M | ---7.24M | ---3.49M | ---8.54M |
| -Special items of operating expenditure | -6.84%-4.14M | -6.01%-16M | -1.85%-11.19M | -3.80%-7.51M | -11.22%-3.88M | -76.78%-15.09M | ---10.98M | ---7.24M | ---3.49M | ---8.54M |
| Operating profit | 6.73%1.29B | 5.60%1.89B | 3.11%2.65B | 4.55%1.96B | 4.65%1.21B | 1.74%1.79B | -22.72%2.57B | -25.17%1.87B | -22.69%1.15B | -39.61%1.76B |
| Share of profits of associates | 595.81%15.37M | 1,215.71%12.43M | 16.91%-8.45M | -62.70%-6.02M | -109.46%-3.1M | 93.58%-1.11M | -143.06%-10.17M | -115.61%-3.7M | -106.06%-1.48M | 82.99%-17.35M |
| Earning before tax | 8.28%1.31B | 6.36%1.9B | 3.19%2.64B | 4.43%1.95B | 4.51%1.21B | 2.69%1.79B | -23.57%2.56B | -26.02%1.87B | -24.03%1.15B | -38.03%1.74B |
| Tax | -16.56%-221.07M | -88.53%8.84M | -26.27%-338.57M | -29.78%-286.12M | -16.87%-189.66M | -35.72%77.04M | 46.02%-268.13M | 46.56%-220.46M | 41.72%-162.29M | 157.82%119.84M |
| After-tax profit from continuing operations | 6.74%1.08B | 2.44%1.91B | 0.48%2.3B | 1.05%1.67B | 2.49%1.02B | 0.21%1.86B | -19.65%2.29B | -22.01%1.65B | -20.06%991.22M | -28.48%1.86B |
| Earning After tax | 6.74%1.08B | 2.44%1.91B | 0.48%2.3B | 1.05%1.67B | 2.49%1.02B | 0.21%1.86B | -19.65%2.29B | -22.01%1.65B | -20.06%991.22M | -28.48%1.86B |
| Minority profit | 4,239.82%14.28M | 213.01%13.89M | -53.21%20.98M | -29.42%39M | -98.62%329K | -231.30%-12.29M | -54.33%44.83M | -18.57%55.25M | -54.14%23.78M | -94.73%9.36M |
| Profits attributable to shareholders | 5.37%1.07B | 1.03%1.9B | 1.56%2.28B | 2.10%1.63B | 4.98%1.02B | 1.39%1.88B | -18.41%2.24B | -22.12%1.59B | -18.57%967.45M | -23.62%1.85B |
| Basic earnings per share | 9.09%0.12 | 6.67%0.16 | 0.00%0.25 | 0.00%0.18 | 0.00%0.11 | 0.00%0.15 | -16.67%0.25 | -21.74%0.18 | -15.38%0.11 | -6.25%0.15 |
| Diluted earnings per share | 9.09%0.12 | 6.67%0.16 | 0.00%0.25 | 0.00%0.18 | 0.00%0.11 | 0.00%0.15 | -16.67%0.25 | -21.74%0.18 | -15.38%0.11 | -6.25%0.15 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | ShinWing Certified Public Accountants (Hong Kong) Limited, ShinWing Certified Public Accountants (Special General Partnership) | -- | -- | -- | ShinWing Certified Public Accountants (Hong Kong) Limited, ShinWing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.